QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
University of Pittsburgh
Marengo Therapeutics, Inc.
Fate Therapeutics
Incyte Corporation
Incyte Corporation